AnalystsMohit BansalMohit Bansal's Stock Forecasts
AnalystsMohit Bansal
Analyst Ranking
Top 8%
#303 out of 4126 analysts
Average Return
+16.8%
Win Rate
75%24 out of 32
Risk vs Reward
Poor
Good
Mohit Bansal's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Avexis IncAVXS | +199.09% | $72.83 | $217.83 | 2017-05-23 - 2018-05-15 | Strong Buy |
Avantor IncAVTR | +175.70% | $10.41 | $28.70 | 2020-03-20 - 2021-03-19 | Strong Buy |
Avexis IncAVXS | +127.47% | $95.76 | $217.83 | 2017-10-02 - 2018-05-15 | Strong Buy |
Adaptimmune Therapeutics PLCADAP | +65.88% | $3.40 | $5.64 | 2020-04-27 - 2021-04-27 | Strong Buy |
Vertex Pharmaceuticals IncVRTX | +54.20% | $208.41 | $321.37 | 2021-12-09 - 2022-12-02 | Strong Buy |
Mohit Bansal's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Xenon Pharmaceuticals IncXENE | 1 | Strong Buy | $50.00 | +28.57% | Initiates Coverage On | 7 days ago |
Halozyme Therapeutics IncHALO | 1 | Strong Buy | $65.00 | +9.35% | Initiates Coverage On | 7 days ago |
Pfizer IncPFE | 4 | Strong Buy | $54.00 | +6.07% | Maintains | a month ago |
Eli Lilly & CoLLY | 4 | Hold | $365.00 | -2.60% | Maintains | a month ago |
Neurocrine Biosciences IncNBIX | 2 | Hold | $120.00 | -5.37% | Maintains | a month ago |
Merck & Co IncMRK | 3 | Strong Buy | $110.00 | -0.04% | Maintains | a month ago |
Vertex Pharmaceuticals IncVRTX | 4 | Strong Buy | $335.00 | +4.24% | Maintains | a month ago |
Gilead Sciences IncGILD | 4 | Hold | $75.00 | -15.76% | Maintains | a month ago |
Biogen IncBIIB | 5 | Strong Buy | $350.00 | +17.10% | Maintains | 2 months ago |
Cerevel Therapeutics Holdings IncCERE | 1 | Strong Buy | $38.00 | +28.21% | Initiates Coverage On | 2 months ago |
Regeneron Pharmaceuticals IncREGN | 5 | Strong Buy | $800.00 | +4.39% | Maintains | 3 months ago |
Bristol Myers Squibb CoBMY | 3 | Hold | $70.00 | -13.72% | Maintains | 7 months ago |
Abbvie IncABBV | 2 | Strong Buy | $200.00 | +22.20% | Maintains | 7 months ago |
Amgen IncAMGN | 2 | Hold | $250.00 | -12.44% | Maintains | 10 months ago |
9 Meters Biopharma IncNMTR | 1 | Strong Buy | $3.00 | N/A | Initiates Coverage On | 2 years ago |
Forte Biosciences IncFBRX | 1 | Strong Buy | $75.00 | N/A | Initiates Coverage On | 2 years ago |
Gracell Biotechnologies IncGRCL | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | 2 years ago |
Radius Health IncRDUS | 1 | Strong Buy | $30.00 | N/A | Maintains | 2 years ago |
Alexion Pharmaceuticals IncALXN | 1 | Hold | $175.00 | N/A | Downgrades | 2 years ago |
Shattuck Labs IncSTTK | 1 | Strong Buy | $36.00 | N/A | Initiates Coverage On | 2 years ago |
Myokardia IncMYOK | 1 | Hold | $225.00 | N/A | Downgrades | 2 years ago |
Biomarin Pharmaceutical IncBMRN | 1 | Hold | $86.00 | N/A | Downgrades | 2 years ago |
Adaptimmune Therapeutics PLCADAP | 1 | Strong Buy | $5.00 | N/A | Maintains | 3 years ago |
Calithera Biosciences IncCALA | 1 | Strong Buy | $7.00 | N/A | Maintains | 3 years ago |
Avantor IncAVTR | 1 | Strong Buy | $11.00 | N/A | Maintains | 3 years ago |
Audentes Therapeutics IncBOLD | 2 | Hold | $28.00 | N/A | Maintains | 4 years ago |
Avexis IncAVXS | 2 | Strong Buy | $116.00 | N/A | Maintains | 5 years ago |
©2022 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.